Joenja (Leniolisib) Receives MHRA Approval for Children Aged 4–11 Years Weighing at Least 27 kg with APDS
Pharming announced that the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has approved an extension of the marketing authorization of Joenja, an oral, selective phosphoinositide 3-kinase delta… read more.
